The Prebiotic Effect of Daily Intake of Orange Juice Affects the Bioavailability of Flavanones?

April 25, 2017 updated by: Thais Cesar, São Paulo State University

Influence of the Prebiotic Effect of Orange Juice on the Bioavailability of Flavanones After Chronic Intake of Orange Juice.

This study aimed investigate the chronic effect of orange juice consumption on gut microbiota and in the bioavailability of flavanones and metabolites by feces, blood and urine analysis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Non-randomized study with interrupted time series and open-label, in which women were enrolled and advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages during 30 days before of intervention (n=10; BMI 23.8 kg/m2; 28 years). After 30 days, the participants will consume during 60 days 300 mL of orange juice daily. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and in the bioavailability of its flavanones. The recruitment process began in September 2016 and the intervention was carried out from October 2016 to February 2017, and the data analysis will start in February 2017. The sample number took into account variances on blood hesperitin levels with a type I error α = 0.05 and a type II error β = 0.2 (80% power) (Silveira et al., 2015). The minimum sample size should have six individuals into the same group. Considering an approximately 15% dropout rate, the final sample size of study was constituted by 10 women. Primary endpoint is the changes in total bacteria population (Lactobacillus spp., Bifidobacterium spp., and reduction of Clostridium spp.) that can result in increased of butyric, acetic, and propionic acid concentrations, and reduction of ammonium production. Secondary endpoint is enhancement of bioavailability of flavanones (hesperitin, naringenin) and metabolites in the blood, urine and feces. Kolmogorov Smirnov and Levene test will be used to assess the normality and homogeneity of data, respectively. One-way analysis of variance (ANOVA) will be apply to determine the intervention effect over the time 0, 30 day, 60 day, 90 day, and 120 day). P significance was set up ≤ 0.05.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sao Paulo
      • Araraquara, Sao Paulo, Brazil, 14800-903
        • Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Healthy women BMI 18.5 - 29.9 kg/m2.

Exclusion Criteria:

Gastrointestinal diseases Pregnant women Regular use of medications Dietary restrictions, vegetarian diet, macrobiotic, etc. Use of vitamins or dietary supplements Use of probiotics or prebiotics in the last 3 months and antibiotics in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Orange juice
Ten women will consume 100% orange juice (300 mL/day) during 60 days.
Thirty days before the beginning of trial, women (n= 10; BMI 23.8 kg/m2; 28 years) will be advised to not consumed foods containing prebiotic, probiotic and fibers, and citrus fruits and beverages. After 30 days, the participants will consume 300 mL of orange juice daily during 60 days. After 60 days of orange juice intervention, the participants will be submitted to 30 days of washout. Samples of blood, urine and feces will collect in five different occasions (baseline, 30 day, 60 day, 90 day, and 120 day) in order to evaluate the prebiotic effect of orange juice on gut microbiota and the bioavailability of its flavanones in blood, urine and feces.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total counting of aerobic bacteria and facultative anaerobic bacteria
Time Frame: 4 months
4 months
Determination of butyric acid
Time Frame: 4 months
4 months
Determination of acetic acid
Time Frame: 4 months
4 months
Ammonium concentration
Time Frame: 4 mounths
4 mounths

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bioavailability of hesperitin and naringenin in the blood, urine and feces
Time Frame: 4 months
Quantification of hesperidin and naringenin and identification and quantification of their metabolites in the blood, urine and feces
4 months
Body mass index
Time Frame: 4 months
4 months
Body lean mass
Time Frame: 4 months
4 months
Body fat mass
Time Frame: 4 months
4 months
% body fat
Time Frame: 4 months
4 months
Ratio waist/hip
Time Frame: 4 mounths
4 mounths
Glucose
Time Frame: 4 mounths
4 mounths
Insulin
Time Frame: 4 mounths
4 mounths
Total cholesterol
Time Frame: 4 mounths
4 mounths
Low density lipoprotein cholesterol
Time Frame: 4 mounths
4 mounths
High density lipoprotein cholesterol
Time Frame: 4 mounths
4 mounths
Triglycerides
Time Frame: 4 mounths
4 mounths
hsCRP
Time Frame: 4 mounths
4 mounths
Alkaline phosphatase
Time Frame: 4 mounths
4 mounths
Aspartate enzyme aminotransferase
Time Frame: 4 mounths
4 mounths
Alanine enzyme aminotransferase
Time Frame: 4 mounths
4 mounths
GammaGT
Time Frame: 4 mounths
4 mounths
Glycemic curve
Time Frame: 4 mounths
4 mounths
Insulin curve
Time Frame: 4 mounths
4 mounths

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thais B Cesar, PhD, São Paulo State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Actual)

October 1, 2016

Study Completion (Actual)

February 1, 2017

Study Registration Dates

First Submitted

January 6, 2017

First Submitted That Met QC Criteria

January 24, 2017

First Posted (Estimate)

January 26, 2017

Study Record Updates

Last Update Posted (Actual)

April 26, 2017

Last Update Submitted That Met QC Criteria

April 25, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

There is still no decision regarding if the individual participant data (IPD) will be available to other researchers.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intestinal Diseases

Clinical Trials on Orange juice

Subscribe